Precigen (PGEN) EBT Margin Growth (1y) (2013 - 2026)
Precigen (PGEN) EBT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Precigen |
1.32 Bn |
1.32 Bn |
20.69 Mn |
400,415.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
400,415.00 |
| Dec 31, 2025 |
85,446.00 |
| Jun 30, 2025 |
-6.94 Mn |
| Mar 31, 2025 |
1.32 Mn |
| Dec 31, 2024 |
134,958.00 |
| Sep 30, 2024 |
197.74 Mn |
| Jun 30, 2024 |
-783,318.00 |
| Mar 31, 2024 |
-1.02 Mn |
| Dec 31, 2023 |
-287,381.00 |
| Sep 30, 2023 |
-197.97 Mn |
| Jun 30, 2023 |
-25,535.00 |
| Mar 31, 2023 |
-659,911.00 |
| Dec 31, 2022 |
-10,658.00 |
| Sep 30, 2022 |
35,182.00 |
| Jun 30, 2022 |
-8,569.00 |
| Mar 31, 2022 |
-34,521.00 |
| Dec 31, 2021 |
46,996.00 |
| Sep 30, 2021 |
-67,451.00 |
| Jun 30, 2021 |
-76,053.00 |
| Mar 31, 2021 |
-1,960.00 |
